MEXICO CITY: Mexico has acquired the primary doses of a COVID-19
vaccine candidate from Chinese language pharmaceutical firm CanSino Biologics Inc. for a late stage-trial on between 10,000 and 15,000 volunteers, international minister Marcelo Ebrard stated on Tuesday.
The nation goals to vaccinate practically all of its inhabitants towards COVID-19 by the tip of 2021 after reaching accords with pharmaceutical firms and the World Well being Group-backed COVAX plan.
“On October 30, the primary doses had been acquired to hold out section three of medical trials of the candidate vaccine from Cansino Bio,” Ebrard stated at a information convention, including that it might be one of many world’s largest COVID-19 medical trials.
Disclaimer: This submit has been auto-published from an company feed with none modifications to the textual content and has not been reviewed by an editor